Going Global to Meet Local Needs

Strategic Alliance
Under Lihpao LifeScience Group

Lihpao Group taking an attitude of caring about the quality of life and home health of the public generations, following the founding of Lihpao Construction Group、Fullon Hotel and Lihpao Paradise, stepping into the biomedical industry and establishing Lihpao Life Science business group.TO LIH LPAO GROUP
The Lihpao Life Science Business Group knows that all medical behaviors come from diagnosis, recognizes that treatment is not as good as prevention, and starts with personalized medicine, predictable and preventive medical services as the development direction. Lihpao Life Science has footprint in both Taiwan & Mainland China.
Libo Pharma is an innovation-center works with worldwide partner to accelerate novel therapeutics development. In the virtual variant of the federated model, Libo Pharma Corp. operations are outsourced and the company itself acts as a management hub, coordinating the activities of its partners.
Leopard Gene is derived from the core spirit of Lihpao Life Science Corp. and has developed a unique corporate culture branding gene; and assists global employees in their professional fields to strive for excellence, unite and show brilliant together.
Leopard Cell is committed to creating a more dignified life and medical treatment for cancer patients. Therefore, Leopard Cell focuses on strengthening the medical quality and needs of each different patient, and develops stem cells, immune cells, cell therapy

Global Partnership

Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer.

Libo Pharma Corp. get into the partnership to co-development HemaMax on July-2021.
Crown Bioscience is a division of JSR Life Sciences, part of the multinational JSR Corporation. As contract research organization, Crown Bioscience offers preclinical drug discovery and development services including translational platforms to advance oncology, immuno-oncology and inflammatory disorders.

Libo Pharma Corp. get into the long-term partnership with Crown Bioscience in immuno-oncology translational study.